Condition category
Respiratory
Date applied
11/03/2009
Date assigned
21/04/2009
Last edited
21/04/2009
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Prof O C Burghuber

ORCID ID

Contact details

Ludwig Boltzmann Institue for COPD
Sanatoriumstrasse 2
Vienna
1140
Austria

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

NA

Study information

Scientific title

Nordic walking to improve functional exercise capacity and daily physical activities in chronic obstructive pulmonary disease (COPD): a randomised controlled trial

Acronym

Study hypothesis

The aim of the present study was to determine whether and to what extent Nordic walking is feasible in increasing functional exercise capacity in patients with chronic obstructive pulmonary disease (COPD). Additionally, we aimed to determine short- and long-term effects of Nordic walking on daily physical activity level, exercise performance and mood status in patients with COPD.

Ethics approval

Ethics Committee of Vienna (Ethikkommission der Stadt Wien), approved on 15/03/2006 (ref: EK 06-058-VK)

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Condition

Chronic obstructive pulmonary disease (COPD)

Intervention

The participants were randomised to either the intervention or control group:

Intervention group: 12 weeks outdoor Nordic walking exercise programme (1 hour per session, 3 times/week)
Control group: no exercise intervention

Patients randomised to the intervention group trained 3 times a week for 1 hour at recommended 75% of their initial maximum heart frequency obtained during initial maximum exercise test. In addition, the participants in the intervention group attended 1 hour/week educational sessions on pulmonary pathophysiology, management of breathlessness and exacerbations, clearance of pulmonary secretions, smoking cessation, medication and nutrition.

The control group received 1 hour/month educational sessions.

Intervention type

Other

Phase

Not Applicable

Drug names

Primary outcome measures

Functional exercise capacity, assessed using the six minute walking test (6MWT).

All primary and secondary outcome measures will be assessed at baseline and after 3, 6, and 9 month.

Secondary outcome measures

1. Daily physical activities, assessed using a tri-axial accelerometer (DynaPort® Activity Monitor; McRoberts BV, Netherlands)
2. Exercise-induced dyspnoea, assessed using the modified Borg Dyspnoea Scale
3. Mood status, assessed using the Hospital Anxiety and Depression Scale (HADS)

All primary and secondary outcome measures will be assessed at baseline and after 3, 6, and 9 month.

Overall trial start date

01/03/2006

Overall trial end date

01/03/2007

Reason abandoned

Eligibility

Participant inclusion criteria

1. Both males and females, age >18 years
2. Stable COPD (no infection or exacerbation for at least 12 weeks)
3. Absence of severe and/or unstable cardiac diseases (myocardial infarction within the last 6 month, cardiac arrhythmia Lown classification >IIIb, as shown by electrocardiogram during rest and maximal exercise test)
4. Absence of other pathologic conditions that could impair daily physical activities (cerebrovascular diseases, rheumatism, symptomatic osteoporosis and others)

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

60

Participant exclusion criteria

Does not meet inclusion criteria

Recruitment start date

01/03/2006

Recruitment end date

01/03/2007

Locations

Countries of recruitment

Austria

Trial participating centre

Ludwig Boltzmann Institue for COPD
Vienna
1140
Austria

Sponsor information

Organisation

Ludwig Boltzmann Institute for COPD (Ludwid Boltzmann Institut für COPD) (Austria)

Sponsor details

Sanatoriumstrasse 2
Vienna
1140
Austria

Sponsor type

Research organisation

Website

http://www.lbg.ac.at

Funders

Funder type

Research organisation

Funder name

Ludwig Boltzmann Institute for COPD (Ludwid Boltzmann Institut für COPD) (Austria) - http://www.lbg.ac.at

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes